GSK makes a lit­tle his­to­ry while out­lin­ing a fa­mil­iar fu­ture

Glax­o­SmithK­line made phar­ma his­to­ry to­day by ap­point­ing Em­ma Walm­s­ley as the first woman to run a glob­al drug mak­er. And she will have to mea­sure up to the best in the busi­ness if GSK is to break out of the rut it finds it­self in.

The phar­ma gi­ant made some ma­jor turns un­der An­drew Wit­ty: swap­ping can­cer drugs for vac­cines and cash with No­var­tis, in­sist­ing on adopt­ing an eth­i­cal stance in con­sumer sales and break­ing up its re­search teams in­to small­er, more ag­ile units.

This article is for premium subscribers only

Upgrade to a premium subscription plan for unlimited access, and join our community of key biopharma players.

UPGRADE